Novo Nordisk

Boxes of Wegovy made by Novo Nordisk are seen at a pharmacy in London, Britain March 8, 2024. Photo: REUTERS/Hollie Adams/File Photo
Health

Novo's trial of weight-loss drug shows improvement in fatty liver disease

The study used 2.4 milligram dose of semaglutide to treat a liver condition called metabolic dysfunction-associated steatohepatitis, or MASH, in one part of the trial involving 800 patients

Headquarter of  Novo Nordisk, a leading global healthcare company operating in the Human insulin market. Photo: Collected
Global Economy

Weight-loss drug forecasts jump to $150 billion as supply grows

Novo Nordisk launches once-a-week diabetes drug
Pharma

Novo Nordisk launches once-a-week diabetes drug

Winnie Estrup Petersen, Ambassador, The Royal Embassy of Denmark in Bangladesh, Dr. Mihail Briciu, Managing Director of Novo Nordisk Bangladesh and Professor Dr. AK Azad Khan, President of Diabetic Association of Bangladesh (BADAS), along with others attend at the launching ceremony of world’s fastest acting insulin at a hotel in the capital on Thursday.
Health

Novo Nordisk introduces world’s fastest acting insulin

Novo Nordisk Bangladesh plants 1,000 trees to support environment
Environment

Novo Nordisk Bangladesh plants 1,000 trees to support environment